Back

Heparin pre-treatment in patients with ST elevation myocardial infarction: a cohort study investigating the effects on coronary artery occlusion, mortality, and bleeding

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Optimising PCI: imaging, pharmacology and more Adjunctive Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Mr Oskar Love Emilsson

Lund (Sweden)

3 More presentations in this session

Presentation thumbnail
Effect of aspirin discontinuation according to individualised patient bleeding and ischemic risks after PCI: a TWILIGHT trial sub-analysis.
Doctor G. Mendieta Badimon (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Intravascular ultrasound-guided optimization for chronic total occlusion-percutaneous coronary intervention with multiple drug-eluting stents
Doctor S. Seo (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Shockwave intravascular lithotripsy (IVL) for calcified coronary lesions; a real world multicentre European study with long term follow up
Doctor W. Raja (Birmingham, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Optimising PCI: imaging, pharmacology and more

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Heparin pretreatment in patients with ST-segment elevation myocardial infarction: a meta-analysis
thumbnail
Congress Presentation
Pretreatment with parenteral anticoagulation in patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis
thumbnail
Congress Presentation
Discussion: READAPT into perspective - Guidelines vs real-world evidence results

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources